Lyra Therapeutics Stock Analysis

Lyra Stock Analysis Notes

About 51.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lyra Therapeutics has Price/Earnings To Growth (PEG) ratio of 1.61. The entity recorded a loss per share of 1.43. The firm had not issued any dividends in recent years. Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts. Lyra Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 60 people. To find out more about Lyra Therapeutics contact Maria Palasis at 617 393 4600 or learn more at https://lyratherapeutics.com.

Lyra Therapeutics Investment Alerts

Lyra Therapeutics Upcoming and Recent Events

Lyra Largest EPS Surprises

View All Earnings Estimates

Lyra Stock Institutional Investors

Note, although Lyra Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lyra Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.53 M.

Lyra Profitablity

Management Efficiency

Lyra Therapeutics has return on total asset (ROA) of (0.3633) % which means that it has lost $0.3633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8499) %, meaning that it created substantial loss on money invested by shareholders. Lyra Therapeutics' management efficiency ratios could be used to measure how well Lyra Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of March 22, 2025, Return On Tangible Assets is expected to decline to -1.48. In addition to that, Return On Capital Employed is expected to decline to -1.88. At present, Lyra Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 97.5 M, whereas Non Current Assets Total are forecasted to decline to about 13.7 M.

Technical Drivers

As of the 22nd of March, Lyra Therapeutics secures the Risk Adjusted Performance of 0.0268, downside deviation of 6.03, and Mean Deviation of 2.89. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lyra Therapeutics, as well as the relationship between them.

Lyra Therapeutics Price Movement Analysis

Lyra Therapeutics Insider Trading Activities

Lyra Therapeutics Outstanding Bonds

Lyra Therapeutics Predictive Daily Indicators

Lyra Therapeutics Forecast Models

Lyra Therapeutics' time-series forecasting models are one of many Lyra Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lyra Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Lyra Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lyra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lyra Therapeutics. By using and applying Lyra Stock analysis, traders can create a robust methodology for identifying Lyra entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lyra analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lyra analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Lyra Therapeutics stock analysis indicators help investors evaluate how Lyra Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Lyra Therapeutics shares will generate the highest return on investment. By understating and applying Lyra Therapeutics stock analysis, traders can identify Lyra Therapeutics position entry and exit signals to maximize returns.

When running Lyra Therapeutics' price analysis, check to measure Lyra Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra Therapeutics is operating at the current time. Most of Lyra Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lyra Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra Therapeutics' price. Additionally, you may evaluate how the addition of Lyra Therapeutics to your portfolios can decrease your overall portfolio volatility.